Preclinical News and Research

RSS
Nuvilex to continue development of acquired live-cell encapsulation technology

Nuvilex to continue development of acquired live-cell encapsulation technology

U.Va. and Epsilon partner to provide commercial version of computer-based diabetes simulation tool

U.Va. and Epsilon partner to provide commercial version of computer-based diabetes simulation tool

Janssen, Jubilant partner for drug discovery in the field of neuroscience

Janssen, Jubilant partner for drug discovery in the field of neuroscience

Marshall Edwards' Triphendiol pre-clinical study data now available in Anti-Cancer Drugs website

Marshall Edwards' Triphendiol pre-clinical study data now available in Anti-Cancer Drugs website

Genentech, FORMA enter structurally innovative agreement for small molecule cancer program

Genentech, FORMA enter structurally innovative agreement for small molecule cancer program

EnVivo initiates EVP-0962 GSM Phase 1 clinical trial for Alzheimer’s disease

EnVivo initiates EVP-0962 GSM Phase 1 clinical trial for Alzheimer’s disease

Flamel, Digna Biotech enter joint development agreement for multiple products

Flamel, Digna Biotech enter joint development agreement for multiple products

Positive results from Stealth's Bendavia Phase I renal impairment study

Positive results from Stealth's Bendavia Phase I renal impairment study

Positive data from Lyxumia study on type 2 diabetes presented at ADA 2011

Positive data from Lyxumia study on type 2 diabetes presented at ADA 2011

New data from Zafgen's ZGN-433 Phase 1b study on obesity presented at ADA 2011

New data from Zafgen's ZGN-433 Phase 1b study on obesity presented at ADA 2011

Lithium can prevent aggregation of toxic proteins and cell loss linked with Parkinson's

Lithium can prevent aggregation of toxic proteins and cell loss linked with Parkinson's

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Idera presents IMO-3100 data on preclinical model of arthritis at FOCIS 2011

Idera presents IMO-3100 data on preclinical model of arthritis at FOCIS 2011

BioMarin to acquire Pfizer's Ireland manufacturing plant

BioMarin to acquire Pfizer's Ireland manufacturing plant

FDA grants Fast Track designation for Repligen's RG3039 to treat Spinal Muscular Atrophy

FDA grants Fast Track designation for Repligen's RG3039 to treat Spinal Muscular Atrophy

Insight into future development of global pharmaceutical industry

Insight into future development of global pharmaceutical industry

AstraZeneca, Jubilant announce delivery outcomes and early success in Pain therapeutic area

AstraZeneca, Jubilant announce delivery outcomes and early success in Pain therapeutic area

Molecularly targeted glue for cancer

Molecularly targeted glue for cancer

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

VENENUM opens new medicinal chemistry facility in Hamilton, NJ

VENENUM opens new medicinal chemistry facility in Hamilton, NJ

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.